Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases
Patrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2013
NCCN Task Force Report: Bone Health In Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
November 9, 2023
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases
E Michael Lewiecki, Teresita Bellido, John P Bilezikian, et al.
JNCI Cancer Spectrum
|
July 31, 2018
The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management
Monica Girotra, Aaron Hansen, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN Task Force Report: Bone Health in Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Breast Cancer Research and Treatment
|
August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Jennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Gynecologic Oncology
|
June 9, 2019
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N Moore, Camille C Gunderson, Paul Sabbatini, et al.
JCO Oncology Practice
|
November 3, 2025
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer
Aaron P Mitchell, Andrew Salner, Paul Palyca, et al.
The Oncologist
|
August 13, 2008
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy
Cherry L Estilo, Catherine H Van Poznak, Tijaana Wiliams, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 20, 2020
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE <i>EXECUTIVE SUMMARY</i>
Pauline M Camacho, Steven M Petak, Neil Binkley, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases
Patrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2013
NCCN Task Force Report: Bone Health In Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
November 9, 2023
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases
E Michael Lewiecki, Teresita Bellido, John P Bilezikian, et al.
JNCI Cancer Spectrum
|
July 31, 2018
The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management
Monica Girotra, Aaron Hansen, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN Task Force Report: Bone Health in Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Breast Cancer Research and Treatment
|
August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Jennifer R Diamond, Carlos Becerra, Donald Richards, et al.
Gynecologic Oncology
|
June 9, 2019
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N Moore, Camille C Gunderson, Paul Sabbatini, et al.
JCO Oncology Practice
|
November 3, 2025
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer
Aaron P Mitchell, Andrew Salner, Paul Palyca, et al.
The Oncologist
|
August 13, 2008
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy
Cherry L Estilo, Catherine H Van Poznak, Tijaana Wiliams, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 20, 2020
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE <i>EXECUTIVE SUMMARY</i>
Pauline M Camacho, Steven M Petak, Neil Binkley, et al.
Page
of 5